SR
Syntax Research’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Hold |
245
| – | – | 0.09% | 68 |
|
|
2025
Q1 | $155K | Hold |
245
| – | – | 0.11% | 70 |
|
|
2024
Q4 | $175K | Hold |
245
| – | – | 0.13% | 65 |
|
|
2024
Q3 | $258K | Sell |
245
-100
| -29% | -$105K | 0.17% | 58 |
|
|
2024
Q2 | $363K | Hold |
345
| – | – | 0.29% | 46 |
|
|
2024
Q1 | $332K | Hold |
345
| – | – | 0.25% | 52 |
|
|
2023
Q4 | $303K | Hold |
345
| – | – | 0.25% | 51 |
|
|
2023
Q3 | $284K | Buy |
+345
| New | +$284K | 0.23% | 53 |
|